Implanet announced initial positive results following use of the Jazz Lock® spinal implant in >25 cases. Full global launch is slated to occur by the end of 2016.
Lattice Biologics closed a private placement for gross proceeds of up to US $0.75MM to fund M&A and the acquisition of donors to support production of an amniotic fluid product for regenerative use. The novel regenerative therapeutic will target osteoarthritis, spine, sports-medicine, foot/ankle and other indications.Â
Vertebral Technologies entered into a strategic partnership with BioMedical Technologies International to distribute InterFuse S™ and T™ spinal fusion devices throughout Mexico.
In2Bones SAS has merged with In2Bones USA, its largest distributor, to form i2b, a global company serving the upper and lower extremities orthopaedic markets.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more